ARCHIVES

NCI Names 15 to Director’s Consumer Liaison Group.

This article is from The Cancer Letter archive.

Vol. 31 No. 02 | January 14, 2005

Download PDF Visit The Full Archive

Related Articles

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

OAM Director Jacobs To Leave; Cites “Conflict with Conscience”

July 15, 1994

NI Consortium for cancer Genetics; Working Group to Meet

March 29, 1996

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

NCI Reorganization Task Forces Near Decisions On New Division’s Makeup; Terry May Be Canidate

May 25, 1979